Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

A budget impact model for biosimilar infliximab in Crohn’s disease in Bulgaria, the Czech Republic, Hungary, Poland, Romania, and Slovakia

PaperCitations, authors & open-access status

A budget impact model for biosimilar infliximab in Crohn’s disease in Bulgaria, the Czech Republic, Hungary, Poland, Romania, and Slovakia is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 72 citations, 2015 year and closed oa status.

72
Citations
2015
Year
closed
OA Status

Related on ScholarIQ

Fanni Rencz
Author
Expert Review of Pharmacoeconomics & Outcomes Research
Journal
Biosimilars and Bioanalytical Methods
Topic
Biosimilars and Bioanalytical Methods
Topic
Inflammatory Bowel Disease
Topic
Pharmaceutical Economics and Policy
Topic
470M+ articles · free account